Quercitrin inhibits platelet activation in arterial thrombosis

Phytomedicine. 2021 Jan:80:153363. doi: 10.1016/j.phymed.2020.153363. Epub 2020 Oct 7.

Abstract

Background: The ingestion of flavonoids has been reported to be associated with reduced cardiovascular disease risk. Quercitrin is a common flavonoid in nature, and it exhibits antioxidant properties. Although the process of thrombogenesis is intimately related to cardiovascular disease risk, it is unclear whether quercitrin plays a role in thrombogenesis.

Purpose: The aim of this study was to examine the antiplatelet effect of quercitrin in platelet activation.

Methods: Platelet aggregation, granule secretion, calcium mobilization, and integrin activation were used to assess the antiplatelet activity of quercitrin. Antithrombotic effect was determined in mouse using ferric chloride (FeCl3)-induced arterial thrombus formation in vivo and thrombus formation on collagen-coated surfaces under arteriolar shear in vitro. Transection tail bleeding time was used to evaluate whether quercitrin inhibited primary hemostasis.

Results: Quercitrin significantly impaired collagen-related peptide-induced platelet aggregation, granule secretion, reactive oxygen species generation, and intracellular calcium mobilization. Outside-in signaling of αIIbβ3 integrin was significantly inhibited by quercitrin in a concentration-dependent manner. The inhibitory effect of quercitrin resulted from inhibition of the glycoprotein VI-mediated platelet signal transduction during cell activation. Further, the antioxidant effect is derived from decreased phosphorylation of components of the TNF receptor-associated factor 4/p47phox/Hic5 axis signalosome. Oral administration of quercitrin efficiently blocked FeCl3-induced arterial thrombus formation in vivo and thrombus formation on collagen-coated surfaces under arteriolar shear in vitro, without prolonging bleeding time. Studies using a mouse model of ischemia/reperfusion-induced stroke indicated that treatment with quercitrin reduced the infarct volume in stroke.

Conclusions: Our results demonstrated that quercitrin could be an effective therapeutic agent for the treatment of thrombotic diseases.

Keywords: Flavonoids; Glycoprotein VI; Platelet; Quercitrin; Thrombosis.

MeSH terms

  • Adenosine Triphosphate / metabolism
  • Animals
  • Arteries
  • Calcium / metabolism
  • Dose-Response Relationship, Drug
  • Fibrinolytic Agents / pharmacology*
  • Hemostasis / drug effects*
  • Humans
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Phosphorylation / drug effects
  • Platelet Activation / drug effects
  • Platelet Aggregation / drug effects
  • Platelet Aggregation Inhibitors / pharmacology
  • Platelet Glycoprotein GPIIb-IIIa Complex / metabolism
  • Platelet Membrane Glycoproteins / metabolism
  • Quercetin / adverse effects
  • Quercetin / analogs & derivatives*
  • Quercetin / pharmacology
  • Reperfusion Injury / chemically induced
  • Thrombosis / chemically induced
  • Thrombosis / drug therapy*
  • Thrombosis / metabolism

Substances

  • Fibrinolytic Agents
  • Platelet Aggregation Inhibitors
  • Platelet Glycoprotein GPIIb-IIIa Complex
  • Platelet Membrane Glycoproteins
  • platelet membrane glycoprotein VI
  • quercitrin
  • Adenosine Triphosphate
  • Quercetin
  • Calcium